Fig. 3From: Clinical features, genomic profiling, and outcomes of adult patients with unifocal Langerhans cell histiocytosisTreatments and outcomes of adult patients with unifocal LCH. *One patient had not yet begun treatment at the time of the last follow-up. CR complete response, VCR vincristine, VDS vindesine, MA methotrexate combined with cytarabine, CHOP cyclophosphamide, epirubicin, vindesine, prednisoneBack to article page